People_

Dr Nicole Wong Doo

MBBS (Hons), PhD, FRACP, FRCPA, GradCert(ClnTch)

Senior Staff Specialist Haematologist
Senior Lecturer
Concord Clinical School
Faculty of Medicine and Health

Phone

+61 2 97676648

Websites

Concord Haematology

Biographical details

Dr Nicole Wong Doo (MBBS (Hons), PhD, FRACP, FRCPA, GradCert[ClinTch]) is a clinical and laboratory haematologist at Concord Repatriation General Hospital, senior lecturer at Concord Clinical School and Honorary Research Associate at the Cancer Council Victoria. In 2023, she was appointed as NSW Councillor of the Haematology Society of Australia and New Zealand.

Current projects

2020 - current: Patient experiences in taking oral blood cancer medicines.

2011- current:

Improving Management by Participatory Research in Oncology; a Victorian Experiment (IMPROVE): Multiple Myeloma and Diffuse Large B Cell Lymphoma. Victorian Cancer Agency Translational Cancer Research Funding.

The Epidemiology of Multiple Myeloma in Australia (EMMA). Cancer Council Victoria.

Associations

Haematology Society of Australia and New Zealand

Royal Australasian College of Physicians

Royal College of Pathologists Australasia

Australasian Leukaemia and Lymphoma Group

Themes

Cancer

Keywords

Education, Epidemiology, Haematological malignancy

Approaches

Education, Epidemiology, Genetics

Publications

By Type

Expand all

Journals

Binkley, M., Hendrickson, P., Hopkins, D., Ng, A., Casulo, C., Baron, J., Roberts, K., Al Kendi, J., Balogh, A., Ricardi, U., Wong Doo, N., et al (2024). International Prognostic Score for Nodular Lymphocyte-Predominant Hodgkin Lymphoma. Journal of Clinical Oncology, 42(19), 2271-2280. [More Information]
Hawkes, E., Lewis, K., Wong Doo, N., Patil, S., Miskin, H., Sportelli, P., Kolibaba, K., Normant, E., Turpuseema, T., Cheah, C. (2023). 17th International Conference on Malignant Lymphoma, Palazzo dei Congressi, Lugano, Switzerland, 13 - 17 June, 2023. Hematological Oncology, 41, 579-580. [More Information]
Tariq, B., Ou, Y., Stern, J., Mundra, V., Wong Doo, N., Walker, P., Lewis, K., Lin, C., Novotny, W., Sahasranaman, S., et al (2023). A phase 1, open-label, randomized drug-drug interaction study of zanubrutinib with moderate or strong CYP3A inhibitors in patients with B-cell malignancies. Leukemia & Lymphoma, 64(2), 329-338. [More Information]
Nguyen, J., Wellard, C., Chung, E., Cheah, C., Dickinson, M., Wong Doo, N., Keane, C., Talaulikar, D., Berkahn, L., Morgan, S., et al (2023). Clinical characteristics of Australian treatment-naïve patients with classical Hodgkin lymphoma from the lymphoma and related diseases registry. European Journal of Haematology, 110(4), 386-395. [More Information]
Cheah, S., Vajdic, C., van Leeuwen, M., Wong Doo, N., Harrison, S., English, D., Giles, G., Milne, R., Bassett, J., Bruinsma, F., Joshua, D., et al (2023). Modifiable lifestyle risk factors and survival after diagnosis with multiple myeloma. Expert Review of Hematology, 16(10), 773-783. [More Information]
Nagaratnam, S., Harinesan, N., Wijesinghe, R., Wong Doo, N., Lyons, A., Morris, K., Triplett, J. (2023). Painless progressive mononeuritis multiplex secondary to AML associated neuroleukemiosis. Journal of Neuroimmunology, 377. [More Information]
Wilson, M., Eyre, T., Kirkwood, A., Wong Doo, N., Soussain, C., Choquet, S., Martinez-Calle, N., Preston, G., Ahearne, M., Schorb, E., et al (2022). Timing of high-dose methotrexate CNS prophylaxis in DLBCL: a multicenter international analysis of 1384 patients. Blood, 139(16), 2499-2511. [More Information]
Islam, S., Cullen, T., Sumpton, D., Damodaran, A., Heath, D., Bosco, A., Wong Doo, N., Kidson-Gerber, G., Cheong, A., Lawford, R., et al (2022). VEXAS syndrome: lessons learnt from an early Australian case series. Internal Medicine Journal, 52(4), 658-662. [More Information]
Wong Doo, N., Trotman, J. (2021). 2+2 in the long term: informing a new standard of care in 2021 for early stage, unfavourable Hodgkin lymphoma. The Lancet Haematology, 8(4), e243-e245. [More Information]
Barrow, T., Wong Doo, N., Milne, R., Giles, G., Willmore, E., Strathdee, G., Byun, H. (2021). Analysis of retrotransposon subfamily DNA methylation reveals novel early epigenetic changes in chronic lymphocytic leukemia. Haematologica, 106(1), 98-110. [More Information]
Dugue, P., Bassett, J., Wong, E., Joo, J., Li, S., Yu, C., Schmidt, D., Makalic, E., Wong Doo, N., Buchanan, D., et al (2021). Biological Aging Measures Based on Blood DNA Methylation and Risk of Cancer: A Prospective Study. JNCI Cancer Spectrum, 5(1), pkaa109. [More Information]
Chong, J., Curtain, C., Gad, F., Passam, F., Soo, G., Levy, R., Dunkley, S., Wong Doo, N., Cunich, M., Burke, R., Chen, V. (2021). Development and implementation of venous thromboembolism stewardship across a hospital network. International Journal of Medical Informatics, 155, 104575. [More Information]
Moore, A., Kane, E., Wang, Z., Panagiotou, O., Teras, L., Monnereau, A., Wong Doo, N., Machiela, M., Skibola, C., Slager, S., et al (2020). Genetically Determined Height and Risk of Non-hodgkin Lymphoma. Frontiers in Oncology, 9, 1539. [More Information]
Gagliardi, A., Dugue, P., Nøst, T., Southey, M., Buchanan, D., Schmidt, D., Makalic, E., Hodge, A., English, D., Wong Doo, N., et al (2020). Stochastic epigenetic mutations are associated with risk of breast cancer, lung cancer, and mature b-cell neoplasms. Cancer Epidemiology Biomarkers and Prevention, 29(10), 2026-2037. [More Information]
Din, L., Sheikh, M., Kosaraju, N., Smedby, K., Bernatsky, S., Berndt, S., Skibola, C., Nieters, A., Wang, S., McKay, J., Wong Doo, N., et al (2019). Genetic overlap between autoimmune diseases and non-Hodgkin lymphoma subtypes. Genetic epidemiology, 43(7), 844-863. [More Information]
Soo, G., Wong Doo, N., Burrows, J., Ritchie, A., Zhang, J., Burke, R. (2019). Improving the adoption of an electronic clinical decision support tool and evaluating its effect on venous thromboembolism prophylaxis prescribing at a Sydney tertiary teaching hospital. Journal of Pharmacy Practice and Research, 49(6), 508-516. [More Information]
Loi, E., Moi, L., Fadda, A., Satta, G., Zucca, M., Sanna, S., Nia, S., Cabras, G., Padoan, M., Magnani, C., Wong Doo, N., et al (2019). Methylation alteration of SHANK1 as a predictive, diagnostic and prognostic biomarker for chronic lymphocytic leukemia. Oncotarget, 10(48), 4987-5002. [More Information]
Wong Doo, N., White, V., Martin, K., Bassett, J., Prince, H., Harrison, D., Jefford, M., Winship, I., Millar, J., Milne, R., et al (2019). The use of optimal treatment for DLBCL is improving in all age groups and is a key factor in overall survival, but non-clinical factors influence treatment. Cancers, 11(7), 1-12. [More Information]
Thillainadesan, J., Ng, L., Cunningham, I., Wong Doo, N., Naganathan, V. (2018). Characteristics of older people in an inpatient haematology unit: A descriptive study. Australasian Journal on Ageing, 37(4), 293-299. [More Information]
Wang, S., Carrington, M., Berndt, S., Slager, S., Bracci, P., Voutsinas, J., Cerhan, J., Smedby, K., Hjalgrim, H., Vijai, J., Kricker, A., et al (2018). HLA class I and II diversity contributes to the etiologic heterogeneity of non-Hodgkin lymphoma subtypes. Cancer Research, 78(14), 4086-4096. [More Information]
Oberoi, D., White, V., Seymour, J., Prince, H., Harrison, S., Jefford, M., Winship, I., Hill, D., Bolton, D., Doo, N., et al (2017). Distress and unmet needs during treatment and quality of life in early cancer survivorship: a longitudinal study of haematological cancer patients. European Journal of Haematology, 99(5), 423-430. [More Information]
Oberoi, D., White, V., Seymour, J., Prince, H., Harrison, S., Jefford, M., Winship, I., Hill, D., Bolton, D., Kay, A., et al (2017). The course of anxiety, depression and unmet needs in survivors of diffuse large B cell lymphoma and multiple myeloma in the early survivorship period. Journal of Cancer Survivorship, 11(3), 329-338. [More Information]
Oberoi, D., White, V., Seymour, J., Prince, H., Harrison, S., Jefford, M., Winship, I., Hill, D., Bolton, D., Kay, A., et al (2017). The influence of unmet supportive care needs on anxiety and depression during cancer treatment and beyond: a longitudinal study of survivors of haematological cancers. Supportive Care in Cancer, 25(11), 3447-3456. [More Information]
Wong Doo, N., Makalic, E., Joo, J., Vajdic, C., Schmidt, D., Wong, E., Jung, C., Severi, G., Park, D., Chung, J., et al (2016). Global measures of peripheral blood-derived DNA methylation as a risk factor in the development of mature B-cell neoplasms. Epigenomics, 8(1), 55-66. [More Information]
Wong Doo, N., Coory, M., White, V., Harrison, S., Prince, H., Millar, J., Dimech, M., Giles, G. (2014). Low Uptake of Upfront Autologous Transplantation for Myeloma in a Jurisdiction With Universal Health Care Coverage: A Population-Based Patterns of Care Study in Australia. Clinical Lymphoma, Myeloma and Leukemia, 14(1), 61-67. [More Information]
Wong Doo, N., Thompson, P., Prince, H., Seymour, J., Ritchie, D., Stokes, K., Burbury, K., Wolf, M., Joyce, T., Harrison, S. (2013). Bortezomib with high dose melphalan conditioning for autologous transplant is safe and effective in patients with heavily pretreated and high risk multiple myeloma. Leukemia & Lymphoma, 54(7), 1465-1472. [More Information]

show 23 more

By Year

Expand all

2024

Binkley, M., Hendrickson, P., Hopkins, D., Ng, A., Casulo, C., Baron, J., Roberts, K., Al Kendi, J., Balogh, A., Ricardi, U., Wong Doo, N., et al (2024). International Prognostic Score for Nodular Lymphocyte-Predominant Hodgkin Lymphoma. Journal of Clinical Oncology, 42(19), 2271-2280. [More Information]

2023

Hawkes, E., Lewis, K., Wong Doo, N., Patil, S., Miskin, H., Sportelli, P., Kolibaba, K., Normant, E., Turpuseema, T., Cheah, C. (2023). 17th International Conference on Malignant Lymphoma, Palazzo dei Congressi, Lugano, Switzerland, 13 - 17 June, 2023. Hematological Oncology, 41, 579-580. [More Information]
Tariq, B., Ou, Y., Stern, J., Mundra, V., Wong Doo, N., Walker, P., Lewis, K., Lin, C., Novotny, W., Sahasranaman, S., et al (2023). A phase 1, open-label, randomized drug-drug interaction study of zanubrutinib with moderate or strong CYP3A inhibitors in patients with B-cell malignancies. Leukemia & Lymphoma, 64(2), 329-338. [More Information]
Nguyen, J., Wellard, C., Chung, E., Cheah, C., Dickinson, M., Wong Doo, N., Keane, C., Talaulikar, D., Berkahn, L., Morgan, S., et al (2023). Clinical characteristics of Australian treatment-naïve patients with classical Hodgkin lymphoma from the lymphoma and related diseases registry. European Journal of Haematology, 110(4), 386-395. [More Information]
Cheah, S., Vajdic, C., van Leeuwen, M., Wong Doo, N., Harrison, S., English, D., Giles, G., Milne, R., Bassett, J., Bruinsma, F., Joshua, D., et al (2023). Modifiable lifestyle risk factors and survival after diagnosis with multiple myeloma. Expert Review of Hematology, 16(10), 773-783. [More Information]
Nagaratnam, S., Harinesan, N., Wijesinghe, R., Wong Doo, N., Lyons, A., Morris, K., Triplett, J. (2023). Painless progressive mononeuritis multiplex secondary to AML associated neuroleukemiosis. Journal of Neuroimmunology, 377. [More Information]

show 2 more

2022

Wilson, M., Eyre, T., Kirkwood, A., Wong Doo, N., Soussain, C., Choquet, S., Martinez-Calle, N., Preston, G., Ahearne, M., Schorb, E., et al (2022). Timing of high-dose methotrexate CNS prophylaxis in DLBCL: a multicenter international analysis of 1384 patients. Blood, 139(16), 2499-2511. [More Information]
Islam, S., Cullen, T., Sumpton, D., Damodaran, A., Heath, D., Bosco, A., Wong Doo, N., Kidson-Gerber, G., Cheong, A., Lawford, R., et al (2022). VEXAS syndrome: lessons learnt from an early Australian case series. Internal Medicine Journal, 52(4), 658-662. [More Information]

2021

Wong Doo, N., Trotman, J. (2021). 2+2 in the long term: informing a new standard of care in 2021 for early stage, unfavourable Hodgkin lymphoma. The Lancet Haematology, 8(4), e243-e245. [More Information]
Barrow, T., Wong Doo, N., Milne, R., Giles, G., Willmore, E., Strathdee, G., Byun, H. (2021). Analysis of retrotransposon subfamily DNA methylation reveals novel early epigenetic changes in chronic lymphocytic leukemia. Haematologica, 106(1), 98-110. [More Information]
Dugue, P., Bassett, J., Wong, E., Joo, J., Li, S., Yu, C., Schmidt, D., Makalic, E., Wong Doo, N., Buchanan, D., et al (2021). Biological Aging Measures Based on Blood DNA Methylation and Risk of Cancer: A Prospective Study. JNCI Cancer Spectrum, 5(1), pkaa109. [More Information]
Chong, J., Curtain, C., Gad, F., Passam, F., Soo, G., Levy, R., Dunkley, S., Wong Doo, N., Cunich, M., Burke, R., Chen, V. (2021). Development and implementation of venous thromboembolism stewardship across a hospital network. International Journal of Medical Informatics, 155, 104575. [More Information]

show 1 more

2020

Moore, A., Kane, E., Wang, Z., Panagiotou, O., Teras, L., Monnereau, A., Wong Doo, N., Machiela, M., Skibola, C., Slager, S., et al (2020). Genetically Determined Height and Risk of Non-hodgkin Lymphoma. Frontiers in Oncology, 9, 1539. [More Information]
Gagliardi, A., Dugue, P., Nøst, T., Southey, M., Buchanan, D., Schmidt, D., Makalic, E., Hodge, A., English, D., Wong Doo, N., et al (2020). Stochastic epigenetic mutations are associated with risk of breast cancer, lung cancer, and mature b-cell neoplasms. Cancer Epidemiology Biomarkers and Prevention, 29(10), 2026-2037. [More Information]

2019

Din, L., Sheikh, M., Kosaraju, N., Smedby, K., Bernatsky, S., Berndt, S., Skibola, C., Nieters, A., Wang, S., McKay, J., Wong Doo, N., et al (2019). Genetic overlap between autoimmune diseases and non-Hodgkin lymphoma subtypes. Genetic epidemiology, 43(7), 844-863. [More Information]
Soo, G., Wong Doo, N., Burrows, J., Ritchie, A., Zhang, J., Burke, R. (2019). Improving the adoption of an electronic clinical decision support tool and evaluating its effect on venous thromboembolism prophylaxis prescribing at a Sydney tertiary teaching hospital. Journal of Pharmacy Practice and Research, 49(6), 508-516. [More Information]
Loi, E., Moi, L., Fadda, A., Satta, G., Zucca, M., Sanna, S., Nia, S., Cabras, G., Padoan, M., Magnani, C., Wong Doo, N., et al (2019). Methylation alteration of SHANK1 as a predictive, diagnostic and prognostic biomarker for chronic lymphocytic leukemia. Oncotarget, 10(48), 4987-5002. [More Information]
Wong Doo, N., White, V., Martin, K., Bassett, J., Prince, H., Harrison, D., Jefford, M., Winship, I., Millar, J., Milne, R., et al (2019). The use of optimal treatment for DLBCL is improving in all age groups and is a key factor in overall survival, but non-clinical factors influence treatment. Cancers, 11(7), 1-12. [More Information]

show 1 more

2018

Thillainadesan, J., Ng, L., Cunningham, I., Wong Doo, N., Naganathan, V. (2018). Characteristics of older people in an inpatient haematology unit: A descriptive study. Australasian Journal on Ageing, 37(4), 293-299. [More Information]
Wang, S., Carrington, M., Berndt, S., Slager, S., Bracci, P., Voutsinas, J., Cerhan, J., Smedby, K., Hjalgrim, H., Vijai, J., Kricker, A., et al (2018). HLA class I and II diversity contributes to the etiologic heterogeneity of non-Hodgkin lymphoma subtypes. Cancer Research, 78(14), 4086-4096. [More Information]

2017

Oberoi, D., White, V., Seymour, J., Prince, H., Harrison, S., Jefford, M., Winship, I., Hill, D., Bolton, D., Doo, N., et al (2017). Distress and unmet needs during treatment and quality of life in early cancer survivorship: a longitudinal study of haematological cancer patients. European Journal of Haematology, 99(5), 423-430. [More Information]
Oberoi, D., White, V., Seymour, J., Prince, H., Harrison, S., Jefford, M., Winship, I., Hill, D., Bolton, D., Kay, A., et al (2017). The course of anxiety, depression and unmet needs in survivors of diffuse large B cell lymphoma and multiple myeloma in the early survivorship period. Journal of Cancer Survivorship, 11(3), 329-338. [More Information]
Oberoi, D., White, V., Seymour, J., Prince, H., Harrison, S., Jefford, M., Winship, I., Hill, D., Bolton, D., Kay, A., et al (2017). The influence of unmet supportive care needs on anxiety and depression during cancer treatment and beyond: a longitudinal study of survivors of haematological cancers. Supportive Care in Cancer, 25(11), 3447-3456. [More Information]

2016

Wong Doo, N., Makalic, E., Joo, J., Vajdic, C., Schmidt, D., Wong, E., Jung, C., Severi, G., Park, D., Chung, J., et al (2016). Global measures of peripheral blood-derived DNA methylation as a risk factor in the development of mature B-cell neoplasms. Epigenomics, 8(1), 55-66. [More Information]

2014

Wong Doo, N., Coory, M., White, V., Harrison, S., Prince, H., Millar, J., Dimech, M., Giles, G. (2014). Low Uptake of Upfront Autologous Transplantation for Myeloma in a Jurisdiction With Universal Health Care Coverage: A Population-Based Patterns of Care Study in Australia. Clinical Lymphoma, Myeloma and Leukemia, 14(1), 61-67. [More Information]

2013

Wong Doo, N., Thompson, P., Prince, H., Seymour, J., Ritchie, D., Stokes, K., Burbury, K., Wolf, M., Joyce, T., Harrison, S. (2013). Bortezomib with high dose melphalan conditioning for autologous transplant is safe and effective in patients with heavily pretreated and high risk multiple myeloma. Leukemia & Lymphoma, 54(7), 1465-1472. [More Information]

Page not found

Dr Nicole Wong Doo

Publications

By Type

By Year